These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20965717)

  • 1. Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases.
    Uchida D; Onoue T; Kuribayashi N; Tomizuka Y; Tamatani T; Nagai H; Miyamoto Y
    Eur J Cancer; 2011 Feb; 47(3):452-9. PubMed ID: 20965717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.
    Uchida D; Onoue T; Tomizuka Y; Begum NM; Miwa Y; Yoshida H; Sato M
    Mol Cancer Res; 2007 Jul; 5(7):685-94. PubMed ID: 17634424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.
    Uchida D; Begum NM; Almofti A; Nakashiro K; Kawamata H; Tateishi Y; Hamakawa H; Yoshida H; Sato M
    Exp Cell Res; 2003 Nov; 290(2):289-302. PubMed ID: 14567988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer.
    Kuribayashi N; Uchida D; Kinouchi M; Takamaru N; Tamatani T; Nagai H; Miyamoto Y
    PLoS One; 2013; 8(11):e80773. PubMed ID: 24236200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma.
    Uchida D; Begum NM; Tomizuka Y; Bando T; Almofti A; Yoshida H; Sato M
    Lab Invest; 2004 Dec; 84(12):1538-46. PubMed ID: 15492752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of miR-518c-5p to growth and metastasis in oral cancer.
    Kinouchi M; Uchida D; Kuribayashi N; Tamatani T; Nagai H; Miyamoto Y
    PLoS One; 2014; 9(12):e115936. PubMed ID: 25536052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
    Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
    World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of CXCR4 in human salivary gland cancers.
    Uchida D; Kuribayashi N; Kinouchi M; Ohe G; Tamatani T; Nagai H; Miyamoto Y
    Clin Exp Metastasis; 2013 Feb; 30(2):133-42. PubMed ID: 22847686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
    Uchida D; Onoue T; Begum NM; Kuribayashi N; Tomizuka Y; Tamatani T; Nagai H; Miyamoto Y
    Mol Cancer; 2009 Aug; 8():62. PubMed ID: 19671192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Hara S; Klosek SK; Li C; Shintani S; Hamakawa H
    Int J Oncol; 2006 Jan; 28(1):61-6. PubMed ID: 16327980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells.
    Onoue T; Uchida D; Begum NM; Tomizuka Y; Yoshida H; Sato M
    Int J Oncol; 2006 Nov; 29(5):1133-8. PubMed ID: 17016644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.
    Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M
    Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on CXCR4/SDF-1alpha axis in lymph node metastasis of cervical squamous cell carcinoma.
    Zhang JP; Lu WG; Ye F; Chen HZ; Zhou CY; Xie X
    Int J Gynecol Cancer; 2007; 17(2):478-83. PubMed ID: 17362322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma.
    Jeong WJ; Choi IJ; Park MW; An SY; Jeon EH; Paik JH; Sung MW; Ahn SH
    J Clin Pathol; 2014 Nov; 67(11):992-8. PubMed ID: 25118295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas.
    Oliveira-Neto HH; Silva ET; Leles CR; Mendonça EF; Alencar Rde C; Silva TA; Batista AC
    Tumour Biol; 2008; 29(4):262-71. PubMed ID: 18781098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.